Clinical Chemistry, Malmö
751 – 760 of 1293
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Aberrant expression of cystatin C in prostate cancer is associated with neuroendocrine differentiation.
(
- Contribution to journal › Article
-
Mark
Calibration services in the frame of accredited coagulation EQA schemes - Meeting the IVD directive
(
- Contribution to journal › Article
-
Mark
Effects of factor Xa and protein S on the individual activated protein C-mediated cleavages of coagulation factor Va.
(
- Contribution to journal › Article
-
Mark
Influence of endotoxin challenge on protein S and C4b-binding protein in healthy subjects
(
- Contribution to journal › Letter
-
Mark
Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at -20 {degrees}C.
(
- Contribution to journal › Article
-
Mark
Evaluation of a rapid automated assay for analysis of von Willebrand ristocetin cofactor activity.
(
- Contribution to journal › Article
-
Mark
Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum
(
- Contribution to journal › Article
-
Mark
Characterization of semenogelin proteins in the human retina
(
- Contribution to journal › Article
-
Mark
Immunohistochemical detection of cysteine-rich secretory protein 3 in tissue and in serum from men with cancer or benign enlargement of the prostate gland.
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance - in the absence of factor V Leiden - and pregnancy.
(
- Contribution to journal › Article